About us
About Pharmetheus
History
Mission & Values
Leadership
Scientific advisors
Our team
Social impact (CSR)
Science & Services
Contexts of use
Trial design and analysis
Program strategies and efficiences
Special/specific populations
Special considerations
Regulatory interactions
Pharmetheus Platforms
Model-Informed Drug Development
PBPK & PBBM
Pharmacometrics
QSP
Solutions
Milestone Analysis
Embedded Scientists
Expert Advice
Scientific Publication
Specific services
Model-Informed Bioequivalence & Biosimilarity
Accelerated submission
Concentration-QTc (C-QTc) modeling
Data-driven strategies for pediatric success
Training workshops
Publications
Case studies
Articles
Careers
Working with us
Open positions
Employee stories
Events
News
Contact us
Home
Publications
Potential strategies to optimize CAR-T cell exposure in absence of dose-exposure relationships leveraging cell kinetic/dynamic models
Potential strategies to optimize CAR-T cell exposure in absence of dose-exposure relationships leveraging cell kinetic/dynamic models
Oncology
Pharmacometrics
Clin Pharmacol Ther. 2023 Feb, 113: S58
Mc Laughlin AM